Ki16425 | Debio 0719 | LPA1/3 Antagonist | AmBeed-信号通路专用抑制剂

首页 / 抑制剂/激动剂 / G蛋白偶联受体/G蛋白 / LPA Receptor / Ki16425

Ki16425 {[allProObj[0].p_purity_real_show]}

货号：A114375 同义名： Debio 0719

Ki16425 is a competitive, potent and reversible antagonist to LPA1, LPA2 and LPA3 with Ki of 0.34 μM, 6.5 μM and 0.93 μM, respectively, shows no activity at LPA4, LPA5, LPA6.

Ki16425 化学结构
CAS号：355025-24-0

Ki16425 3D分子结构
CAS号：355025-24-0

规格	价格	会员价	库存	数量
{[ item.pr_size ]}	{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]}	{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]}	{[ getRatePrice(item.pr_rmb, 1,1) ]}	{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]}	现货	咨询	- +

购物车0 收藏询单

sales@ambeed.cn tech@ambeed.cn 400-920-2911 产品手册产品订购技术咨询
快速发货顺丰冷链运输，1-2 天到达

品质保证

技术支持

免费溶解

Ki16425 纯度/质量文件产品仅供科研

货号：A114375 标准纯度： {[allProObj[0].p_purity_real_show]} 产品说明书

批次查询：批次纯度: COA SDS NMR HPLC CNMR LC-MS

全球学术期刊中引用的产品: • JACS Au, 2024. Ambeed. [ A148168 ]; • JMC, 2024. Ambeed. [ A187643 ]; • JMC, 2024. Ambeed. [ A341145 , A633512 , A607865 , A167774 ]; • Biomacromolecules, 2024. Ambeed. [ A110759 ]; • Biomacromolecules, 2024. Ambeed. [ A203543 ]; 更多 >

LPA Receptor 亚型比较

产品名称	LPA1 ↓ ↑	LPA2 ↓ ↑	LPA3 ↓ ↑	纯度
Ki16198	+++ LPA1, Ki: 0.34 μM		++ LPA3, Ki: 0.93 μM	{[allProObj[0].p_purity_real_show]}
ONO-7300243	++++ LPA1, IC50: 0.16 μM			{[allProObj[0].p_purity_real_show]}
Ki16425	+++ LPA1, Ki: 0.34 μM	+ LPA2, Ki: 6.5 μM	++ LPA3, Ki: 0.93 μM	{[allProObj[0].p_purity_real_show]}
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多，抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用，但抑制强度暂时没有相关数据。

Ki16425 生物活性

靶点	LPA2 LPA2, Ki:6.5 μM LPA1 LPA1, Ki:0.34 μM LPA3 LPA3, Ki:0.93 μM
描述	LPA (lysophosphatidic acid), which has been shown to be involved in certain diseases such as atherosclerosis and cancer, can act through its receptor like LPA receptor 1, LPA receptor 2, or LPA receptor 3 and elicit different biological actions, like Ca²⁺ mobilization, changing in cAMP accumulation, changing cell shape and motility, and cell proliferation. Ki16425 is a LPA receptor antagonist with Ki values of 0.34μM for mouse LPA receptor 1 and 0.93μM for human LPA receptor 3, but with much higher Ki value for human LPA receptor 2 (Ki=6.5μM). Pre-treatment with 1μM Ki16425 can inhibit LPA-induced [Ca2²⁺]_i increase in THP-1 cells and 3T3 fibroblasts. Also, Ki16425 could decrease the This LPA-induced response of inositol phosphate production in 3T3 fibroblasts and A431 cells, but not S1P3- or S1P2-expressing CHO cells, at concentration of 10μM. The cAMP accumulation inhibited by LPA in FRTL-5 thyroid cells in a PTX-sensitive manner could be almost completely suppressed by 10μM Ki16425. Cell proliferation and migration induced by LPA in Swiss 3T3 fibroblasts could be inhibited dose-dependently by Ki16425. Treatment with Ki16425 at dose of 10mg/kg intradermally could improve dermal and lung fibrosis in a mouse model of bleomycin-induced murine scleroderma. Pre-treatment with 10μM for 30 minutes could completely block LPA-induced YAP/TAZ phosphorylation and inhibit Hippo signaling pathway in HEK293A cells.
作用机制	Ki16425 can antagonize the binding of LPA to the receptor, thus competitively inhibiting LPA-induced GTP binding and LPA receptor binding to membrane fractions.^[1]

Ki16425 细胞研究

细胞系	浓度	检测类型	检测时间	活动说明	数据源
CHOK1 cells		Function assay		Antagonist activity at human recombinant LPA1 receptor expressed in CHOK1 cells assessed as inhibition of lysophosphatidic acid-induced intracellular calcium influx, IC50=0.51 μM	17467986
HEK293 cells		Function assay	5 mins	Antagonist activity at human LPA1 receptor expressed in HEK293 cells assessed as inhibition of LPA-induced AP-TGF-alpha release treated 5 mins before LPA addition measured after 60 mins	22658556
human chem1 cells		Function assay		Antagonist activity at LPA1 expressed in human chem1 cells assessed as effect on intracellular calcium mobilization by FLIPR assay, IC50=0.046 μM	20056548
PC-3 cells		Function assay		Binding affinity for Lysophosphatidic acid receptor in PC-3 cells, Ki=1.74 μM	16033271

Ki16425 动物研究

Dose

Mice: 1 mg/kg, 10 mg/kg^[2] (i.d.); 20 mg/kg^[4] (i.p.); 5 mg/kg^[5] (i.v.); 25 mg/kg, 50 mg/kg^[5] (p.o.)

Administration

i.d., i.p., i.v., p.o.

Pharmacokinetics

Animal	Mice^[5]
Dose	5 mg/kg (i.v.) 50 mg/kg (p.o.)
Administration	i.v. p.o.
F	14.41% (p.o.)
T_1/2	0.49 h (i.v.) 0.98 h (p.o.)
T_max	0.08 h (i.v.) 0.25 h (p.o.)
CL	6.66 l/h/kg (i.v.)
C_max	2960 μg/ml (i.v.) 1658 μg/ml (p.o.)

Ki16425 参考文献

[1]Ohta H, Sato K, et al. Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors. Mol Pharmacol. 2003 Oct;64(4):994-1005.

[2]Ohashi T, Yamamoto T, et al. Antifibrotic effect of lysophosphatidic acid receptors LPA1 and LPA3 antagonist on experimental murine scleroderma induced by bleomycin. Exp Dermatol. 2015 Sep;24(9):698-702.

[3]Yu FX, Zhao B, et al. Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell. 2012 Aug 17;150(4):780-91.

[4]Sánchez-Marín L, Ladrón de Guevara-Miranda D, et al. Systemic blockade of LPA1/3 lysophosphatidic acid receptors by ki16425 modulates the effects of ethanol on the brain and behavior. Neuropharmacology. 2018 May 1;133:189-201.

[5]David M, Ribeiro J, et al. Targeting lysophosphatidic acid receptor type 1 with Debio 0719 inhibits spontaneous metastasis dissemination of breast cancer cells independently of cell proliferation and angiogenesis. Int J Oncol. 2012 Apr;40(4):1133-41.

Ki16425 实验方案

计算器

存储液制备

1mg

5mg

10mg

1 mM

5 mM

10 mM

2.11mL

0.42mL

0.21mL

10.53mL

2.11mL

1.05mL

21.05mL

4.21mL

2.11mL

Ki16425 技术信息

CAS号	355025-24-0
分子式	C₂₃H₂₃ClN₂O₅S
分子量	474.957

别名	Debio 0719
运输	蓝冰

存储条件

粉末 Sealed in dry,Store in freezer, under -20°C

液体 -20°C:3-6个月-80°C:12个月

溶解度

DMSO: 105 mg/mL(221.07 mM)，注意：DMSO长时间开封后，会吸水并导致溶解能力下降，请避免使用长期开封的DMSO

动物实验配方

细胞研究

细胞系	浓度	检测类型	检测时间	活动说明	数据源

CHOK1 cells	Function assay		Antagonist activity at human recombinant LPA1 receptor expressed in CHOK1 cells assessed as inhibition of lysophosphatidic acid-induced intracellular calcium influx, IC50=0.51 μM	17467986
HEK293 cells	Function assay	5 mins	Antagonist activity at human LPA1 receptor expressed in HEK293 cells assessed as inhibition of LPA-induced AP-TGF-alpha release treated 5 mins before LPA addition measured after 60 mins	22658556
human chem1 cells	Function assay		Antagonist activity at LPA1 expressed in human chem1 cells assessed as effect on intracellular calcium mobilization by FLIPR assay, IC50=0.046 μM	20056548
PC-3 cells	Function assay		Binding affinity for Lysophosphatidic acid receptor in PC-3 cells, Ki=1.74 μM	16033271
rat hepatic stellate cells	Function assay		Antagonist activity at LPA1 receptor in rat hepatic stellate cells assessed as inhibition of lysophosphatidic acid-induced intracellular calcium influx, IC50=0.16 μM	17467986
RH7777 rat hepatoma cells	Function assay		Binding affinity for Lysophosphatidic acid receptor 3 expressed in RH7777 rat hepatoma cells, Ki=0.148 μM	16033271
RH7777 rat hepatoma cells	Function assay		Inhibition of LPA-induced calcium transients in RH7777 rat hepatoma cells expressing LPA3 receptor, IC50=0.301 μM	16033271

Ki16425 {[allProObj[0].p_purity_real_show]}

Ki16425 纯度/质量文件产品仅供科研

全球学术期刊中引用的产品

Ki16425 质控信息

Ki16425 生物活性

Ki16425 细胞研究

Ki16425 动物研究

Ki16425 参考文献

Ki16425 实验方案

Ki16425 技术信息

最近浏览的产品

大规格询价

摩尔计算器

靶点

总药量计算器

工作液计算器

细胞研究

临床研究

确认信息

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

LPA2	LPA2, Ki:6.5 μM
LPA1	LPA1, Ki:0.34 μM
LPA3	LPA3, Ki:0.93 μM

Ki16425 {[allProObj[0].p_purity_real_show]}

Ki16425 纯度/质量文件 产品仅供科研

全球学术期刊中引用的产品

Ki16425 质控信息

Ki16425 生物活性

Ki16425 细胞研究

Ki16425 动物研究

Ki16425 参考文献

Ki16425 实验方案

Ki16425 技术信息

最近浏览的产品

大规格询价

摩尔计算器

靶点

总药量计算器

工作液计算器

细胞研究

临床研究

确认信息

请登录您的专属账户

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

Ki16425 纯度/质量文件产品仅供科研